Su Qing, Xiao Ganyao, Zhou Wei, Du Zhiyun
School of Computer Science and Technology, Guangdong University of Technology, Guangzhou 510006, P. R. China.
School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, P. R. China.
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2023 Aug 25;40(4):753-761. doi: 10.7507/1001-5515.202210067.
It is a significant challenge to improve the blood-brain barrier (BBB) permeability of central nervous system (CNS) drugs in their development. Compared with traditional pharmacokinetic property tests, machine learning techniques have been proven to effectively and cost-effectively predict the BBB permeability of CNS drugs. In this study, we introduce a high-performance BBB permeability prediction model named balanced-stacking-learning based BBB permeability predictor(BSL-B3PP). Firstly, we screen out the feature set that has a strong influence on BBB permeability from the perspective of medicinal chemistry background and machine learning respectively, and summarize the BBB positive(BBB+) quantification intervals. Then, a combination of resampling algorithms and stacking learning(SL) algorithm is used for predicting the BBB permeability of CNS drugs. The BSL-B3PP model is constructed based on a large-scale BBB database (B3DB). Experimental validation shows an area under curve (AUC) of 97.8% and a Matthews correlation coefficient (MCC) of 85.5%. This model demonstrates promising BBB permeability prediction capability, particularly for drugs that cannot penetrate the BBB, which helps reduce CNS drug development costs and accelerate the CNS drug development process.
在中枢神经系统(CNS)药物研发过程中,提高其血脑屏障(BBB)通透性是一项重大挑战。与传统药代动力学性质测试相比,机器学习技术已被证明能有效且经济高效地预测CNS药物的BBB通透性。在本研究中,我们引入了一种名为基于平衡堆叠学习的BBB通透性预测器(BSL - B3PP)的高性能BBB通透性预测模型。首先,我们分别从药物化学背景和机器学习的角度筛选出对BBB通透性有强烈影响的特征集,并总结出BBB阳性(BBB +)量化区间。然后,使用重采样算法和堆叠学习(SL)算法的组合来预测CNS药物的BBB通透性。BSL - B3PP模型基于大规模BBB数据库(B3DB)构建。实验验证表明,曲线下面积(AUC)为97.8%,马修斯相关系数(MCC)为85.5%。该模型展示了良好的BBB通透性预测能力,特别是对于无法穿透BBB的药物,这有助于降低CNS药物研发成本并加速CNS药物研发进程。